Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (100)

2023

  1. Advances in immunotherapy for cervical cancer

    Therapeutic Advances in Medical Oncology, Vol. 15

  2. Advances in immunotherapy in cervical cancer

    International Journal of Gynecological Cancer, Vol. 33, Núm. 3, pp. 403-413

  3. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  4. Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia

    Farmacia Hospitalaria, Vol. 47, Núm. 3, pp. 100-105

  5. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)

    Leukemia

  6. Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3(Front. Microbiol., (2022), 13, (918362), 10.3389/fmicb.2022.918362)

    Frontiers in Microbiology

  7. Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1

    Journal of medical economics, Vol. 26, Núm. 1, pp. 445-453

  8. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

  9. Drug-related problems as reason for emergency department visit: 3 years of the FARM-URG registry

    International Journal of Pharmacy Practice, Vol. 31, Núm. 4, pp. 417-422

  10. Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain

    BMC Pulmonary Medicine, Vol. 23, Núm. 1

  11. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 360-370

  12. Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 21

  13. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)

    Frontiers in Microbiology, Vol. 14